Funded Tech Companies
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical venture, based in Cambridge. Venture investment and financing was provided by Novartis Venture Fund and Blackstone.
Company Overview
Company Name
Anthos Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
101 Main St.
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Anthos Therapeutics is a clinical-stage biopharmaceutical company developing and commercializing innovative therapies for high-risk cardiovascular patients. Anthos is a formation of Blackstone (NYSE: BX) Life Sciences and Novartis AG (NYSE: NVS), one of the worlds' leading pharmaceutical companies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/28/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Nicholas Galakatos
Chief Executive Officer
John Glasspool
Chief Operating Officer
Jonathan Freeman
VP - Operations
Debra Freedholm
Company Investors
- Novartis Venture Fund
- Blackstone
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs